Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACST Historical Stock Prices |
| Preferred Stock Newsletter |
| Top Option Ideas |
| Stock Message Boards |
ACST (ACST) has the following price history information. Looking back at ACST historical stock prices for the last five trading days, on October 21, 2024, ACST opened at $3.27, traded as high as $3.39 and as low as $3.12, and closed at $3.22. Trading volume was a total of 21.30K shares. On October 22, 2024, ACST opened at $3.13, traded as high as $3.30 and as low as $3.13, and closed at $3.29. Trading volume was a total of 20.70K shares. On October 23, 2024, ACST opened at $3.21, traded as high as $3.60 and as low as $3.19, and closed at $3.60. Trading volume was a total of 192.70K shares. On October 24, 2024, ACST opened at $3.54, traded as high as $3.58 and as low as $3.30, and closed at $3.40. Trading volume was a total of 118.90K shares. On October 25, 2024, ACST opened at $3.38, traded as high as $3.45 and as low as $3.20, and closed at $3.37. Trading volume was a total of 27.80K shares.
ACST Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ACST shares, starting with a $10,000 purchase of ACST, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 06/08/2016 | |
| End date: | 10/25/2024 | |
| Start price/share: | $74.88 | |
| End price/share: | $3.37 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -95.50% | |
| Average Annual Total Return: | -30.91% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $450.08 | |
| Years: | 8.39 | |
 | |||||
| ACST Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 10/21/2024 | $3.27 | $3.39 | $3.12 | $3.22 | 21.30K |
| 10/22/2024 | $3.13 | $3.30 | $3.13 | $3.29 | 20.70K |
| 10/23/2024 | $3.21 | $3.60 | $3.19 | $3.60 | 192.70K |
| 10/24/2024 | $3.54 | $3.58 | $3.30 | $3.40 | 118.90K |
| 10/25/2024 | $3.38 | $3.45 | $3.20 | $3.37 | 27.80K |
|
| About ACST |
| Acasti Pharma is a biopharmaceutical company that is focused on developing and commercializing products for rare and orphan diseases by using its drug delivery technologies. Co.'s primary drug candidate, GTX-104, is an IV formulation of nimodipine designed to treat subarachnoid hemorrhage, a rare brain disorder. Co.'s other drug candidates are: GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia, an orphan pediatric genetic neurodegenerative disorder in young children; and GTX-101, which is a topical bioadhesive film-forming bupivacaine spray for Postherpetic Neuralgia, which causes debilitating pain following infection by the shingles virus. |
| ACST Historical Closing Prices | |
| Date | Close |
| 10/21/2024 | $3.22 |
| 10/22/2024 | $3.29 |
| 10/23/2024 | $3.60 |
| 10/24/2024 | $3.40 |
| 10/25/2024 | $3.37 |
| Healthcare Historical Prices |
| ACST is categorized under the Healthcare sector; below are some other companies in the same sector:
ACTU Historical Stock Prices Also explore: ACST shares outstanding history
|
Free ACST Email Alerts:
